Cell & Molecular Technologies, Inc. (CMT)

Cell & Molecular Technologies, Inc. (CMT), formed by the merger of Specialty Media, Inc. and Molecular Cell Science, Inc. in mid-1997, offers state-of-the-art, cost- and time-effective contract R&D services and specialized research products to clients engaged in biopharmaceutical and biotechnology research. CMT's contract research & development activities are distinguished by a close collaborative approach between the client's scientists, CMT's staff scientists, and CMT's academically-based Core Scientific Advisory Board. Through its Specialty Media Division, CMT develops, manufactures, and markets high-quality research products. The Specialty Media Division provides custom-formulated cell culture media, products for gene transfer and expression, and media and reagents for serum-free cell culture, mouse emryo culture, and mouse embryonic stem cells.

Activity:

- Contract Research
- Manufacturing
- Research & Development

Product / Technology type(s) covered:

- Bio
- Reagents
- Technology

Therapeutic targets:

- Genetics

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: